They sensibly pour money into their products. Software is always a case of adding more, either through home-grown inventions or acquisitions.
I can't see that changing; the only thing is that the percentage of revenue that goes to R&D will hopefully become less as revenue grows and profit percentage follows. A similar amount, but a smaller share!
- Forums
- ASX - By Stock
- 6.50 price target
They sensibly pour money into their products. Software is always...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WTC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$132.25 |
Change
2.350(1.81%) |
Mkt cap ! $44.23B |
Open | High | Low | Value | Volume |
$130.44 | $132.50 | $129.75 | $42.44M | 322.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11591 | $131.64 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$132.38 | 51 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11591 | 131.640 |
2 | 1688 | 131.580 |
2 | 172 | 131.550 |
1 | 2648 | 131.510 |
1 | 1688 | 131.280 |
Price($) | Vol. | No. |
---|---|---|
132.500 | 191 | 3 |
132.870 | 200 | 1 |
132.930 | 1688 | 1 |
133.000 | 716 | 5 |
133.240 | 1688 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
WTC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online